Skip to main content
. 2021 Jun 2;3(7):1018–1023. doi: 10.1016/j.jaccas.2021.04.001

Figure 2.

Figure 2

Cardiac Magnetic Resonance Obtained After Acute Heart Failure Following First Dose of Mogamulizumab

(A) Short axis T-2 weighted image showing diffuse high-signal intensity consistent with myocardial edema. (B) Single-shot, short-axis late-gadolinium enhancement image showing hazy mid-myocardial delayed enhancement in the basal inferoseptal wall (arrow).